Breaking News
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
November 17, 2017 - New Kevlar-based hydrogel recreates the magic of natural cartilage

Many Sufferers Denied Pricey New Ldl cholesterol Medicine

image_pdfDownload PDFimage_print

THURSDAY, Sept. 28, 2017 — Dear new drugs be offering hope to sufferers with out of control “unhealthy” ldl cholesterol, however the prime charge helps to keep many sufferers from getting them, a brand new find out about says.

The injectable medication — authorized to be used in america in 2015 — are referred to as PCSK9 inhibitors. They come with Praluent (alirocumab) and Repatha (evolocumab).

However, researchers discovered, of tens of hundreds of sufferers prescribed the medication, just about part have been denied insurance plans. And prime copays perceived to save you many others from filling their prescriptions.

“We have been stunned through how little medical elements — like how prime your ldl cholesterol was once — mattered as to whether or now not you were given authorized,” mentioned find out about lead creator Dr. Ann Marie Navar.

“We are hoping that this research activates a larger overview of ways restricted affected person get right of entry to is to new treatments,” added Navar, an assistant professor of cardiology at Duke Scientific Analysis Institute in Durham, N.C.

Increased LDL levels of cholesterol are a big chance issue for center illness and stroke. The brand new medication are really helpful for sufferers who don’t seem to be successfully handled through statins, the normal cholesterol-lowering medicines. In keeping with researchers, PCSK9 inhibitors paintings through serving to the liver flush the “unhealthy” ldl cholesterol out of the bloodstream through concentrated on a protein known as PCSK9.

The medication charge up to $14,000 a yr, alternatively. And a find out about revealed in August wondered their cost-effectiveness.

This new find out about was once funded through Repatha’s maker, Amgen Inc., founded in Thousand Oaks, Calif.

The findings are “seriously vital,” mentioned Dr. Kim Williams Sr., professor and leader of cardiology at Rush College Faculty of Drugs in Chicago.

“Many affected person are statin-intolerant because of adversarial results,” mentioned Williams, who wasn’t concerned with the find out about. “We want to have PCSK9 inhibitors in our armamentarium when indicated, now not simply when indicated and reasonably priced.”

For the find out about, Navar’s workforce tracked greater than 45,000 sufferers in america who have been prescribed the medication from mid-2015 to mid-2016. Greater than part have been 65 years or older and had executive insurance coverage like Medicare.

Insurers simplest authorized the medicines 47 p.c of the time. And simply 1 in five sufferers were given the approval at the first day, in keeping with the find out about.

“What mattered essentially the most was once who your insurance coverage corporate was once, what form of pharmacy you used, or who the drugstore receive advantages supervisor was once,” Navar mentioned.

Of the sufferers whose prescriptions have been in reality authorized, about one-third by no means crammed them.

Price did not appear to be a subject matter for everybody who did not fill their prescriptions: About eight p.c had a copay of 0. However greater than three-quarters of the ones with copays of greater than $350 by no means were given their medicine, the find out about discovered.

Navar put it in differently: “The vast majority of those that needed to pay not up to $20 a month crammed the prescription. As soon as copays reached about $300 per 30 days, this had dropped to not up to 25 p.c.”

It is not transparent what the medication charge total. “Price for medication is in point of fact a shifting goal,” Navar mentioned. “The sticky label worth is nearly by no means what’s in reality paid.”

That is as a result of pharmacy receive advantages managers and insurance coverage corporations ceaselessly negotiate reductions and rebates with the drug producers, Navar mentioned. “Pharmacy receive advantages managers can, however do not need to, cross alongside the ones reductions to insurers. There is not any solution to in point of fact understand how a lot is being paid for those medication nor how a lot of the cut price is getting again to sufferers,” she defined.

Navar added there may be additionally a “burden on suppliers, who’ve already taken time to speak to sufferers in regards to the dangers and advantages of recent treatment.” Then there may be forms to get it throughout the device, all of which delays remedy, she added.

The find out about additionally highlights demanding situations in drug innovation, Navar mentioned. “On one hand, we wish new remedies and we hail the improvement of recent treatments. However however, now we have but to broaden a device to comprise prices, so get right of entry to to new treatments is restricted,” she famous.

In keeping with Williams, the find out about “issues to a device this is damaged, and threatens to extend the well being care inequalities that we have got been operating to lower.”

The find out about was once revealed Sept. 27 in JAMA Cardiology.

Additional info

For extra about new ldl cholesterol medication, see the U.S.-based Nationwide Lipid Affiliation.

Posted: September 2017

Really helpful for you

Tagged with:

About author

Related Articles